123 related articles for article (PubMed ID: 37487438)
1. CUL4B enhances the malignant phenotype of esophageal squamous cell carcinoma by suppressing TGFBR3 expression.
Gong Q; Wang Y; Zhu K; Bai X; Feng T; Sun G; Wang M; Pan X; Qin C
Biochem Biophys Res Commun; 2023 Oct; 676():58-65. PubMed ID: 37487438
[TBL] [Abstract][Full Text] [Related]
2. CUL4B renders breast cancer cells tamoxifen-resistant via miR-32-5p/ER-α36 axis.
Wang Y; Pan X; Li Y; Wang R; Yang Y; Jiang B; Sun G; Shao C; Wang M; Gong Y
J Pathol; 2021 Jun; 254(2):185-198. PubMed ID: 33638154
[TBL] [Abstract][Full Text] [Related]
3. Dysregulation of the miR-194-CUL4B negative feedback loop drives tumorigenesis in non-small-cell lung carcinoma.
Mi J; Zou Y; Lin X; Lu J; Liu X; Zhao H; Ye X; Hu H; Jiang B; Han B; Shao C; Gong Y
Mol Oncol; 2017 Mar; 11(3):305-319. PubMed ID: 28164432
[TBL] [Abstract][Full Text] [Related]
4. [CRL4B complex promotes the development of pancreatic cancer by inhibiting secreted frizzled related protein 1].
Chen Y; Leng S; Wang Y
Zhonghua Zhong Liu Za Zhi; 2021 Jun; 43(6):646-656. PubMed ID: 34289556
[No Abstract] [Full Text] [Related]
5. CRL4B catalyzes H2AK119 monoubiquitination and coordinates with PRC2 to promote tumorigenesis.
Hu H; Yang Y; Ji Q; Zhao W; Jiang B; Liu R; Yuan J; Liu Q; Li X; Zou Y; Shao C; Shang Y; Wang Y; Gong Y
Cancer Cell; 2012 Dec; 22(6):781-95. PubMed ID: 23238014
[TBL] [Abstract][Full Text] [Related]
6. CUL4B activates Wnt/β-catenin signalling in hepatocellular carcinoma by repressing Wnt antagonists.
Yuan J; Han B; Hu H; Qian Y; Liu Z; Wei Z; Liang X; Jiang B; Shao C; Gong Y
J Pathol; 2015 Apr; 235(5):784-95. PubMed ID: 25430888
[TBL] [Abstract][Full Text] [Related]
7. CRL4B promotes tumorigenesis by coordinating with SUV39H1/HP1/DNMT3A in DNA methylation-based epigenetic silencing.
Yang Y; Liu R; Qiu R; Zheng Y; Huang W; Hu H; Ji Q; He H; Shang Y; Gong Y; Wang Y
Oncogene; 2015 Jan; 34(1):104-18. PubMed ID: 24292684
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of CUL4B Suppresses the Proliferation and Invasion in Non-Small Cell Lung Cancer Cells.
Wang X; Chen Z
Oncol Res; 2016; 24(4):271-7. PubMed ID: 27656838
[TBL] [Abstract][Full Text] [Related]
9. The CUL4B-miR-372/373-PIK3CA-AKT axis regulates metastasis in bladder cancer.
Liu X; Cui J; Gong L; Tian F; Shen Y; Chen L; Wang Y; Xia Y; Liu L; Ye X; Wang M; Liu G; Jiang B; Shao C; Zou Y; Gong Y
Oncogene; 2020 Apr; 39(17):3588-3603. PubMed ID: 32127645
[TBL] [Abstract][Full Text] [Related]
10. TGFBR3 is an independent unfavourable prognostic marker in oesophageal squamous cell cancer and is positively correlated with Ki-67.
Zhang X; Chen Y; Li Z; Han X; Liang Y
Int J Exp Pathol; 2020 Dec; 101(6):223-229. PubMed ID: 33146446
[TBL] [Abstract][Full Text] [Related]
11. Cullin-4B promotes cell proliferation and invasion through inactivation of p53 signaling pathway in colorectal cancer.
Zhong M; Zhou L; Zou J; He Y; Fang Z; Xiang X
Pathol Res Pract; 2021 Aug; 224():153520. PubMed ID: 34153655
[TBL] [Abstract][Full Text] [Related]
12. CUL4B promotes aggressive phenotypes of renal cell carcinoma via upregulating c-Met expression.
Chen S; Wang Y; Chen L; Xia Y; Cui J; Wang W; Jiang X; Wang J; Zhu Y; Sun S; Zou Y; Gong Y; Shi B
Int J Biochem Cell Biol; 2021 Jan; 130():105887. PubMed ID: 33227394
[TBL] [Abstract][Full Text] [Related]
13. CRL4B interacts with and coordinates the SIN3A-HDAC complex to repress CDKN1A and drive cell cycle progression.
Ji Q; Hu H; Yang F; Yuan J; Yang Y; Jiang L; Qian Y; Jiang B; Zou Y; Wang Y; Shao C; Gong Y
J Cell Sci; 2014 Nov; 127(Pt 21):4679-91. PubMed ID: 25189618
[TBL] [Abstract][Full Text] [Related]
14. CUL4B Promotes Breast Carcinogenesis by Coordinating with Transcriptional Repressor Complexes in Response to Hypoxia Signaling Pathway.
Huang W; Zhang J; Huo M; Gao J; Yang T; Yin X; Wang P; Leng S; Feng D; Chen Y; Yang Y; Wang Y
Adv Sci (Weinh); 2021 May; 8(10):2001515. PubMed ID: 34026424
[TBL] [Abstract][Full Text] [Related]
15. Effects of cullin 4B on the proliferation and invasion of human gastric cancer cells.
He F; Cheng XM; Gu WL
Mol Med Rep; 2018 Apr; 17(4):4973-4980. PubMed ID: 29393470
[TBL] [Abstract][Full Text] [Related]
16. CUL4B/miR-33b/C-MYC axis promotes prostate cancer progression.
Zhao M; Qi M; Li X; Hu J; Zhang J; Jiao M; Bai X; Peng X; Han B
Prostate; 2019 Apr; 79(5):480-488. PubMed ID: 30609075
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA SNHG12 induces proliferation, migration, epithelial-mesenchymal transition, and stemness of esophageal squamous cell carcinoma cells via post-transcriptional regulation of BMI1 and CTNNB1.
Wu D; He X; Wang W; Hu X; Wang K; Wang M
Mol Oncol; 2020 Sep; 14(9):2332-2351. PubMed ID: 32239639
[TBL] [Abstract][Full Text] [Related]
18. CUL4B promotes aggressive phenotypes of HNSCC via the activation of the Wnt/β-catenin signaling pathway.
Wang Y; Yue D
Cancer Med; 2019 May; 8(5):2278-2287. PubMed ID: 30883036
[TBL] [Abstract][Full Text] [Related]
19. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
[TBL] [Abstract][Full Text] [Related]
20. LHX2 Enhances the Malignant Phenotype of Esophageal Squamous Cell Carcinoma by Upregulating the Expression of SERPINE2.
Li X; Wu X; Chen H; Liu Z; He H; Wang L
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
